SIMCERE PHARMA (02096) Completes Placement of Existing Shares and Subscription of New Shares Under General Mandate with "Top-up" Arrangement

Stock News

Sep 10

SIMCERE PHARMA (02096) announced that the placement and subscription transactions were completed on September 4, 2025, and September 10, 2025, respectively. All conditions for the placement have been fulfilled, and the placement was completed on September 4, 2025. A total of 121 million sale shares were successfully placed by the placing agent to no fewer than six placees at a placing price of HK$12.95 per sale share. Additionally, all conditions for the subscription have been satisfied, and the subscription was completed on September 10, 2025. A total of 121 million subscription shares (equivalent to the number of sale shares placed under the placement) were subscribed by the vendor at a subscription price of HK$12.95 per subscription share, which is the same as the placing price. The subscription shares represent approximately 4.66% of the total issued share capital of the company as enlarged by the allotment and issue of the subscription shares upon completion of the subscription.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1139990315"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1139990315\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1139990315?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-10 18:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1139990315","market":"nz","top_or_hot":-1,"title":"SIMCERE PHARMA (02096) Completes Placement of Existing Shares and Subscription of New Shares Under General Mandate with \"Top-up\" Arrangement","media":"Stock News","content":"<p>SIMCERE PHARMA (02096) announced that the placement and subscription transactions were completed on September 4, 2025, and September 10, 2025, respectively. All conditions for the placement have been fulfilled, and the placement was completed on September 4, 2025. A total of 121 million sale shares were successfully placed by the placing agent to no fewer than six placees at a placing price of HK$12.95 per sale share. Additionally, all conditions for the subscription have been satisfied, and the subscription was completed on September 10, 2025. A total of 121 million subscription shares (equivalent to the number of sale shares placed under the placement) were subscribed by the vendor at a subscription price of HK$12.95 per subscription share, which is the same as the placing price. The subscription shares represent approximately 4.66% of the total issued share capital of the company as enlarged by the allotment and issue of the subscription shares upon completion of the subscription.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SIMCERE PHARMA (02096) Completes Placement of Existing Shares and Subscription of New Shares Under General Mandate with \"Top-up\" Arrangement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSIMCERE PHARMA (02096) Completes Placement of Existing Shares and Subscription of New Shares Under General Mandate with \"Top-up\" Arrangement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-09-10 18:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SIMCERE PHARMA (02096) announced that the placement and subscription transactions were completed on September 4, 2025, and September 10, 2025, respectively. All conditions for the placement have been fulfilled, and the placement was completed on September 4, 2025. A total of 121 million sale shares were successfully placed by the placing agent to no fewer than six placees at a placing price of HK$12.95 per sale share. Additionally, all conditions for the subscription have been satisfied, and the subscription was completed on September 10, 2025. A total of 121 million subscription shares (equivalent to the number of sale shares placed under the placement) were subscribed by the vendor at a subscription price of HK$12.95 per subscription share, which is the same as the placing price. The subscription shares represent approximately 4.66% of the total issued share capital of the company as enlarged by the allotment and issue of the subscription shares upon completion of the subscription.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"","article_id":"1139990315","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1139990315","pubTimestamp":1757500100,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"SIMCERE PHARMA (02096) announced that the placement and subscription transactions were completed on September 4, 2025, and September 10, 2025, respectively. All conditions for the placement have been...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1583":"高瓴概念","BK1191":"制药","02096":"先声药业"},"translate_title":"先声药业(02096)根据一般授权以“先旧后新”安排完成配售现有股份及认购新股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02096":1},"content_text":"SIMCERE PHARMA (02096) announced that the placement and subscription transactions were completed on September 4, 2025, and September 10, 2025, respectively. All conditions for the placement have been fulfilled, and the placement was completed on September 4, 2025. A total of 121 million sale shares were successfully placed by the placing agent to no fewer than six placees at a placing price of HK$12.95 per sale share. Additionally, all conditions for the subscription have been satisfied, and the subscription was completed on September 10, 2025. A total of 121 million subscription shares (equivalent to the number of sale shares placed under the placement) were subscribed by the vendor at a subscription price of HK$12.95 per subscription share, which is the same as the placing price. The subscription shares represent approximately 4.66% of the total issued share capital of the company as enlarged by the allotment and issue of the subscription shares upon completion of the subscription.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}